FDA.reportPublic FDA data

BUTYL ALCOHOL

Substance profile for UNII 8PJ61P6TS3, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for BUTYL ALCOHOL
Structure render from PubChem CID 263

Substance Identity#

UNII
8PJ61P6TS3
Preferred term
BUTYL ALCOHOL
Registry number
71-36-3
EC number
200-751-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C4H10O
Chemical structure for BUTYL ALCOHOL
Structure render from PubChem CID 263

Chemical And Database Identifiers#

InChIKey
LRHPLDYGYMQRHN-UHFFFAOYSA-N
SMILES
CCCCO
RxCUI
1310579
PubChem
263
NCIt
C76700
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound263pubchem.ncbi.nlm.nih.gov/compound/263
PubChem InChIKey SearchLRHPLDYGYMQRHN-UHFFFAOYSA-Npubchem.ncbi.nlm.nih.gov/#query=LRHPLDYGYMQRHN-UHFFFAOYSA-N
RxNorm1310579mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1310579
NCI ThesaurusC76700ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76700
FDA Substance Registration System8PJ61P6TS3precision.fda.gov/uniisearch/srs/unii/8PJ61P6TS3
European Community number200-751-6commonchemistry.cas.org/results?q=200-751-6

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
LANSOPRAZOLE7
075dbfb1-47c2-4578-a212-f8e656f0e9f92
PANTOPRAZOLE SODIUM2
GLIPIZIDE ER1
TEMAZEPAM1
Indomethacin Extended Release Capsules, USP Rx only2
ESOMEPRAZOLE MAGNESIUM1
Zonisamide1
GABAPENTIN2
DIVALPROEX SODIUM2
These highlights do not include all the information needed to use esomeprazole magnesium safely and effectively. See full prescribing information for esomeprazole magnesium. Esomeprazole magnesium delayed-release capsules USP, for oral use Initial U.S. Approval: 1989 (omeprazole)6
Indomethacin Capsules USP, 25 mg and 50 mg5
These highlights do not include all the information needed to use Calcium Acetate Capsules safely and effectively. See full prescribing information for Calcium Acetate Capsules. Calcium Acetate Capsules for ORAL use. Initial U.S. Approval: 19903
INDOMETHACIN1
These highlights do not include all the information needed to use tacrolimus capsules safely and effectively. See full prescribing information for tacrolimus capsules. TACROLIMUS Capsules, USP for oral use Initial U.S. Approval: 19946
These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. ZIPRASIDONE hydrochloride capsules for oral use Initial U.S. Approval: 20013
Omeprazole DR2
Indomethacin Extended – Release Capsules, USP 75 mg5
These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 19895
These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) Delayed-Release Capsules, for Oral Use NEXIUM (esomeprazole magnesium) For Delayed-Release Oral Suspension Initial U.S. Approval: 1989 (omeprazole)2
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
These highlights do not include all the information needed to use phentermine hydrochloride capsules, USP safely and effectively. See full prescribing information for phentermine hydrochloride capsules, USP. PHENTERMINE Hydrochloride Capsules, USP CIV Initial U.S. Approval: 19592
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
Ursodiol Capsules, USP2
Tamsulosin hydrochloride capsules USP, 0.4 mg These highlights do not include all the information needed to use Tamsulosin hydrochloride safely and effectively. See full prescribing information for Tamsulosin hydrochloride. Tamsulosin hydrochloride (Tamsulosin hydrochloride) CAPSULE for ORAL use. Initial U.S. Approval: 19971
DOXYCYCLINE HYCLATE CAPSULES, USP2
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE delayed-release capsules USP, for oral use INITIAL U.S. APPROVAL: 19891
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE Sodium delayed-release tablets USP for oral use Initial U.S. approval: 20001
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
These highlights do not include all the information needed to use Divalproex Sodium Delayed Release Tablets safely and effectively. See full prescribing information for Divalproex Sodium Delayed Release Tablets. Divalproex Sodium Delayed Release Tablets USP for Oral use. Initial U.S. Approval: 19831
These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 19831
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
These highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
Isotretinoin Capsules USP1
Nexa ® Plus Capsules1
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
Afeditab CR (Nifedipine Extended Release Tablets)4
CEPHALEXIN CAPSULES, USP8
Tamsulosin hydrochloride capsules USP, 0.4 mg These highlights do not include all the information needed to use Tamsulosin hydrochloride safely and effectively. See full prescribing information for Tamsulosin hydrochloride. Tamsulosin hydrochloride (Tamsulosin hydrochloride) CAPSULE for ORAL use. Initial U.S. Approval: 19971
Revised: January 2014 Glipizide Extended-Release Tablets For Oral Use Rx only2
These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP . DULOXETINE delayed-release capsules USP for oral use. Initial U.S. Approval: 20041
These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 19501
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
Lithium Carbonate Capsules USP Rx Only1
Glipizide Extended-Release Tablets Revised: January 2013 Rx only1
These highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
Gabapentin Capsules, USP 100 mg, 300 mg and 400 mg2
These highlights do not include all the information needed to use PANTOPRAZOLE SODIUM safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) TABLET for ORAL use. Initial U.S. Approval: 20073
These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 19501
DOXYCYCLINE HYCLATE CAPSULES, USP Rev. 11/11 Rx Only1
Drug Facts7
Drug Facts5
Drug Facts2
Drug Facts2
These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets, USP Initial U.S. Approval: 19971
These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. Ziprasidone Hydrochloride Capsules for Oral use Initial U.S. Approval: 20013
15f453ac-84b6-455e-9926-f51b8b9ac0dd1
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
MEXILETINE HYDROCHLORIDE CAPSULES USP 8739 8740 8741 Rx only2
CEPHALEXIN CAPSULES, USP1
c70b5045-706e-443a-9be1-d0bc3c5981304
These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 19502
Myorisan TM (isotretinoin capsules, USP) 10 mg, 20 mg, 40 mg2
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP "Initial U.S. Approval:".19896
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
Glipizide Extended-Release Tablets Rx only4
d6a161d9-7e7a-4711-ba0e-c9040c42268d5
Temazepam Capsules, USP Novel Laboratories, Inc. Rx only4
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 01/21/20091
Etodolac Capsules and Tablets, USP2
TussiCaps ® (Hydrocodone Polistirex and Chlorpheniramine Polistirex) Extended-Release Capsules CIII Rx only1
Ampicillin Capsules, USP1
These highlights do not include all the information needed to use phentermine hydrochloride capsules, USP safely and effectively. See full prescribing information for phentermine hydrochloride capsules, USP. PHENTERMINE Hydrochloride Capsules, USP CIV for oral use Initial U.S. Approval: 19592
Ethosuximide Capsules,USP1
2ed81194-be24-45a0-8dde-fbc6ad3d7abe4
IsonaRif™ (Rifampin and Isoniazid Capsules USP) 300 mg/150 mg1
These highlights do not include all the information needed to use Fluoxetine safely and effectively. See full prescribing information for Fluoxetine. Fluoxetine capsules for oral use Initial U.S. Approval: 19871
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
FULL PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE. OMEPRAZOLE DELAYED-RELEASE (omeprazole) capsule, delayed release for oral use Initial U.S. Approval: 19893
These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ. REYATAZ ® (atazanavir sulfate) Capsules Initial U.S. Approval: 20032
Amoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
Hydrochlorothiazide Capsules, 12.5 mg Rx Only3
Dronabinol Capsules, USP CIII Rx only3
DANAZOL CAPSULES, USP Rx only2
RIFAMPIN CAPSULES, USP2
Indomethacin Capsules USP, 25 mg and 50 mg3
9c244c88-dcc4-44fb-b0d9-13732dc705f51
These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION Initial U.S. Approval: 1989 (omeprazole)2
Lithium Carbonate Capsules USP Rx Only6
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use See full prescribing information for use INITIAL U.S. APPROVAL: 20072
Rifampin Capsules, USP1
Indomethacin Extended – Release Capsules, USP 75 mg3231
PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
Indomethacin Extended – Release Capsules, USP 75 mg1
Glipizide Extended-Release Tablets Rx only1
RIFAMPIN CAPSULES, USP2
Strazepam17
These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochloride Capsules USP*, 0.4 mg Initial U.S. Approval: 19971
Indomethacin Capsules USP, 25 mg2
PROPAFENONE HYDROCHLORIDE EXTENDED RELEASE CAPSULES1
These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) Capsules TEMODAR (temozolomide) for Injection administered via intravenous infusion Initial U.S. Approval: 19991
Rifampin Capsules, USP1
Omeprazole 20 mg1
Lithium Carbonate Capsules USP Rx Only4
Lithium Carbonate Capsules USP Rx Only2
DOXEPIN HYDROCHLORIDE CAPSULES, USP2
Temazepam1
These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 20101
Dicyclomine Hydrochloride Tablets, USP Dicyclomine Hydrochloride Capsules, USP Rx Only1
PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
Lithium Carbonate Capsules USP 150 mg, 300 mg and 600 mg2
These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION Initial U.S. Approval: 1989 (omeprazole)1
PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
Rifampin Capsules, USP1
These highlights do not include all the information needed to use Balsalazide Disodium Capsules, 750 mg safely and effectively. See full prescribing information for Balsalazide Disodium Capsules. Balsalazide Disodium Capsules for oral use Initial U.S. Approval: 20001
4b5513c3-b57f-46f1-9855-dad1063aa4c92
LITHIUM CARBONATE CAPSULES, USP Rev. 12/02 Rx Only1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 8PJ61P6TS3 page 1 of 1 · 10 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
BUTYL ALCOHOL8PJ61P6TS371363CAPSULEORAL0.02 mg
BUTYL ALCOHOL8PJ61P6TS371363CAPSULE, COATED, EXTENDED RELEASEORALNA
BUTYL ALCOHOL8PJ61P6TS371363CAPSULE, DELAYED RELEASEORALNA
BUTYL ALCOHOL8PJ61P6TS371363CAPSULE, EXTENDED RELEASEORAL0.01 mg
BUTYL ALCOHOL8PJ61P6TS371363TABLETORAL0.01 mg
BUTYL ALCOHOL8PJ61P6TS371363TABLET, COATEDORALNA
BUTYL ALCOHOL8PJ61P6TS371363TABLET, DELAYED RELEASEORAL0.05 mg
BUTYL ALCOHOL8PJ61P6TS371363TABLET, EXTENDED RELEASEORALNA
BUTYL ALCOHOL8PJ61P6TS371363SOLUTIONTOPICAL0.08 %w/w
BUTYL ALCOHOL8PJ61P6TS371363SWABTOPICAL0.08 %w/w